VIP Call Girl Sector 88 Gurgaon Delhi Just Call Me 9899900591
Venous Thromboembolism Prophylaxis CPG: an ADAPTE Clinical Practice Guideline
1. Venous Thromboembolism
(VTE) Prophylaxis: an
Adapted Evidence-Based
Clinical Practice Guideline
By
Dr. Yasser S. Amer
MBBCh, MPed, MHI, CPHQ, FISQua
CPG Methodologist, CPGs-QMD, KKUH
CPGs Steering Committee, KSUMC
eSiHi Physician (CPOE) Build Team
2. Statement of disclosure
23 May 2017 2
Dr. Yasser S. Amer
MBBCh, MPed, MHI, CPHQ, FISQua
I have no actual or potential,
commercial or academic conflict
of interest to declare in relation
to this presentation/ project
Adaptation of CPG for VTE Prophylaxis
3. 23 May 2017 3
What makes a trustworthy CPG?
Adaptation of CPG for VTE Prophylaxis
4. Standards for high quality CPGs
IOM 2011 – G-I-N 2012 – AGREE 2013
23 May 2017 4Adaptation of CPG for VTE Prophylaxis
5. The CPG lifecycle at KSUMC:
CPG Adaptation Program
23 May 2017 5Adaptation of CPG for VTE Prophylaxis
6. CPG Adaptation Program
King Saud University Medical City
I. Research Chair for Evidence-Based
Health Care and Knowledge Translation
II. Quality Management Department
III. KSUMC-Wide CPG Steering Committee
and 20 CPG Departmental Committees
Collaborative!
23 May 2017 6Adaptation of CPG for VTE Prophylaxis
9. MCW Policy & Procedure for
Synthesis of CPGS in KSUMC
(Updated 2016)
23 May 2017 9Adaptation of CPG for VTE Prophylaxis
10. CPG Authorship group
CPG CHAMPIONS!
Review Group:
Methodology
Review Group:
Clinical Content
Adaptation Group
23 May 2017 10Adaptation of CPG for VTE Prophylaxis
11. Set Up Phase: Team formation
This CPG Adaptation Project was
initiated by the Critical Care
Departmental CPG Committee!
Started Jan 2012 – Ended Feb 2013
Lifespan: 13 months!
23 May 2017 11Adaptation of CPG for VTE Prophylaxis
12. Set Up Phase: Team formation
CPG Adaptation Working Group
Dr. Hadil Al-Otair, MD, ABIM, MRCP (UK)
Dr. Mohammad Azfar, MD, MBBS, MRCP (UK)
Dr. Rafat Taher, MD, FRCS(C)
Mr. Maher Titi, RN, MSN, CPHQ, FISQua
Mr. Mohammed Hussein, RN, MSN, CPHQ, CPPS, CPHRM
Ms. Rawia Abdalla, RN, MSN, CPHQ, CPPS, CPHRM
Ms. Mashael Alsheikh, B.C.P.S
Dr. Yasser Amer, MBBCh, MPed, MHI, CPHQ, FISQua
23 May 2017 12Adaptation of CPG for VTE Prophylaxis
13. Set Up Phase: Topic Selection
VTE = PE & DVT
Rationale
• Preventable hospital complication
• Clinical care gap (E2P)
• Variation in practice
• Accreditation Standard (ROP)
23 May 2017 13Adaptation of CPG for VTE Prophylaxis
14. Health/ Clinical/ Key Questions
Patient (& disease characteristics)
Intervention(s)
Professionals (Target users)
Outcomes (purpose of the CPGs)
Healthcare settings (& context)
23 May 2017 14
CPG Scope: PIPOH Model
Adaptation of CPG for VTE Prophylaxis
Adaptation Phase
15. Inclusion / Exclusion Selection Criteria
Criterion Description
Methods of
Development
EB-CPGs: (Detailed Methodology of Development
Documented; NOT Consensus/Expert-based)
Authors Organization/ Specialized Society
(CPG development groups); NOT single authors.
Country International CPGs
Date of
Publication
2011 – 2013 (last 3 years; at the time of this project)
Language English CPGs
Status Original Source CPG (de novo developed)
NOT Adapted
23 May 2017 Adaptation of CPG for VTE Prophylaxis 15
16. Search and Selection
of Source CPGs
• 8 CPGs DBs searched (NGC, GIN, NICE, SIGN,
ICSI, Ontario GAC, NZGC, Google Sch.)
• 9 Source CPGs retrieved
• 6 CPGs excluded based on PIPOH and
selection criteria
• 3 CPGs included for further appraisal by
AGREE II Instrument.
23 May 2017 16Adaptation of CPG for VTE Prophylaxis
17. 23 May 2017 Adaptation of CPG for VTE Prophylaxis 17
18. 23 May 2017 18Adaptation of CPG for VTE Prophylaxis
19. Quality Assessment of the
Source CPGs
23 May 2017 19Adaptation of CPG for VTE Prophylaxis
20. AGREE II Domain Scores for the 3 source CPGs
ACCP-2012, ICSI-2011, ACP-2011
23 May 2017 20Adaptation of CPG for VTE Prophylaxis
21. Key recommendations
1. VTEP in Medical/Critically ill
Patients
2. VTEP in Non-Orthopedic Surgical
Patients
3. VTEP in Orthopedic Surgical
Patients
4. Anticoagulant dose adjustment
23 May 2017 Adaptation of CPG for VTE Prophylaxis 21
22. Finalization Phase: Reviewers
Clinical Content
Prof. Ahmad Abdulmomen,
MD, FCCM
Dr. Mariam Al Ansari,
MD,FRCSI,FCC
Mr. Hussam Muzain , RN
Mr. Emerita Espanol, RN
Methodology
• Prof. Lubna A. Al-Ansary,
MBBS, MSc, MRCGP, FRCGP
• Dr. Hayfaa Abdelmageed
Ahmed Wahbi, PhD, FRCOG,
FRCS (Ed.), Mmed-Edu
• Dr. Manal Abou Elkheir, BSc,
Pharm D, BCPS
• Dr. Shaikh Iqbal, FRCPCH
23 May 2017 Adaptation of CPG for VTE Prophylaxis 22
23. Dissemination &
Implementation
“Nothing could be more
frustrating than producing a
CPG that is then ignored by
not being disseminated nor
implemented nor updated!”
The concept of the ‘LIVING’
CPG23 May 2017 23Adaptation of CPG for VTE Prophylaxis
25. CPG implementation
strategies
1) Dissemination Process. . .
2) Local Clinical Champions. . .
3) Education & Training. . .
4) Networking with existing projects. .
5) Regular M & E. . .
6) Patients as champions for change.
23 May 2017 25Adaptation of CPG for VTE Prophylaxis
34. 23 May 2017 Adaptation of CPG for VTE Prophylaxis 34
35. 23 May 2017 35Adaptation of CPG for VTE Prophylaxis
36. What is your role as a HCP
in CPGs? “spread the word”
1. CPG implementers/ users.
“Your continuous feedback!”
2. CPG developers/ adapters.
3. Improvement research projects.
23 May 2017 36Adaptation of CPG for VTE Prophylaxis
37. 23 May 2017 37Adaptation of CPG for VTE Prophylaxis